FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285395144> ?p ?o ?g. }

• W4285395144 endingPage "38" @default.
• W4285395144 startingPage "27" @default.
• W4285395144 abstract "This review article discusses the pathophysiological mechanisms of the development of coronavirus infection in obese patients. It has been shown that obesity is considered as the most important risk factor for the development of many comorbid diseases, including severe forms and deaths as a result of a new coronavirus infection. The higher incidence and severity of a new coronavirus infection in obese patients is based on a complex of factors, the main of which are an increase in cardiovascular risk, including a tendency to thrombosis, a decrease in the efficiency of the respiratory system, impaired immune response, and the presence of chronic inflammatory state. The article discusses non-drug approaches and issues of pharmacological therapy in patients with obesity in the context of a pandemic of a new coronavirus infection. It is shown that the implementation of national quarantine measures has led to an increase in physical inactivity, the level of stress and a change in the eating behavior of the population, closing a vicious circle and contributing to an increase in body weight. For this reason, the efforts of physicians of therapeutic specialties should be directed primarily to increasing resistance to infection among obese patients and combating physical inactivity. The main groups of drugs that can be used to combat lipotoxicity are listed. It was noted that infectious disease doctors and endocrinologists can use those groups of drugs that affect the most vulnerable pathogenetic triggers for the development of obesity and comorbidities: hunger and satiety processes, decreased insulin sensitivity, development of lipotoxicity and chronic inflammation. It has been proven that the range of positive effects of new antihyperglycemic drugs from the groups of type 1 glucagon-like peptide agonists and type 2 sodium-glucose transporter inhibitors, combined with a well-studied efficacy and safety profile, represents a new opportunity for the treatment of obesity in the context of a coronavirus infection pandemic." @default.
• W4285395144 created "2022-07-14" @default.
• W4285395144 creator A5027125102 @default.
• W4285395144 creator A5075082898 @default.
• W4285395144 creator A5075358751 @default.
• W4285395144 date "2022-07-13" @default.
• W4285395144 modified "2023-10-06" @default.
• W4285395144 title "Obesity and COVID-19: insights from two pandemics" @default.
• W4285395144 cites W1548759563 @default.
• W4285395144 cites W1557543416 @default.
• W4285395144 cites W1598667444 @default.
• W4285395144 cites W1892123421 @default.
• W4285395144 cites W1989772629 @default.
• W4285395144 cites W1996020742 @default.
• W4285395144 cites W1997332398 @default.
• W4285395144 cites W2014527201 @default.
• W4285395144 cites W2044505861 @default.
• W4285395144 cites W2090086335 @default.
• W4285395144 cites W2096528587 @default.
• W4285395144 cites W2108816189 @default.
• W4285395144 cites W2116218641 @default.
• W4285395144 cites W2120967846 @default.
• W4285395144 cites W2130064617 @default.
• W4285395144 cites W2132588562 @default.
• W4285395144 cites W2137673012 @default.
• W4285395144 cites W2179359265 @default.
• W4285395144 cites W2215494512 @default.
• W4285395144 cites W2466018560 @default.
• W4285395144 cites W2549203425 @default.
• W4285395144 cites W2570869572 @default.
• W4285395144 cites W2792178736 @default.
• W4285395144 cites W2792345506 @default.
• W4285395144 cites W2799455061 @default.
• W4285395144 cites W2804938814 @default.
• W4285395144 cites W2808682716 @default.
• W4285395144 cites W3009314935 @default.
• W4285395144 cites W3009522206 @default.
• W4285395144 cites W3013985628 @default.
• W4285395144 cites W3014080169 @default.
• W4285395144 cites W3015990679 @default.
• W4285395144 cites W3016182787 @default.
• W4285395144 cites W3016304986 @default.
• W4285395144 cites W3017002108 @default.
• W4285395144 cites W3019371629 @default.
• W4285395144 cites W3019708143 @default.
• W4285395144 cites W3025316553 @default.
• W4285395144 cites W3033453353 @default.
• W4285395144 cites W3037635809 @default.
• W4285395144 cites W3041337626 @default.
• W4285395144 cites W3082970280 @default.
• W4285395144 cites W3125326515 @default.
• W4285395144 cites W3126881271 @default.
• W4285395144 cites W3136768371 @default.
• W4285395144 cites W3164687150 @default.
• W4285395144 cites W3168253483 @default.
• W4285395144 cites W3183300604 @default.
• W4285395144 cites W3190989858 @default.
• W4285395144 cites W3202042764 @default.
• W4285395144 cites W4234540033 @default.
• W4285395144 doi "https://doi.org/10.22625/2072-6732-2022-14-2-27-38" @default.
• W4285395144 hasPublicationYear "2022" @default.
• W4285395144 type Work @default.
• W4285395144 citedByCount "1" @default.
• W4285395144 countsByYear W42853951442023 @default.
• W4285395144 crossrefType "journal-article" @default.
• W4285395144 hasAuthorship W4285395144A5027125102 @default.
• W4285395144 hasAuthorship W4285395144A5075082898 @default.
• W4285395144 hasAuthorship W4285395144A5075358751 @default.
• W4285395144 hasBestOaLocation W42853951441 @default.
• W4285395144 hasConcept C126322002 @default.
• W4285395144 hasConcept C151730666 @default.
• W4285395144 hasConcept C177713679 @default.
• W4285395144 hasConcept C203014093 @default.
• W4285395144 hasConcept C2777391703 @default.
• W4285395144 hasConcept C2777648638 @default.
• W4285395144 hasConcept C2779134260 @default.
• W4285395144 hasConcept C2779343474 @default.
• W4285395144 hasConcept C2908647359 @default.
• W4285395144 hasConcept C3008058167 @default.
• W4285395144 hasConcept C44353895 @default.
• W4285395144 hasConcept C511355011 @default.
• W4285395144 hasConcept C524204448 @default.
• W4285395144 hasConcept C71924100 @default.
• W4285395144 hasConcept C86803240 @default.
• W4285395144 hasConcept C89623803 @default.
• W4285395144 hasConcept C99454951 @default.
• W4285395144 hasConceptScore W4285395144C126322002 @default.
• W4285395144 hasConceptScore W4285395144C151730666 @default.
• W4285395144 hasConceptScore W4285395144C177713679 @default.
• W4285395144 hasConceptScore W4285395144C203014093 @default.
• W4285395144 hasConceptScore W4285395144C2777391703 @default.
• W4285395144 hasConceptScore W4285395144C2777648638 @default.
• W4285395144 hasConceptScore W4285395144C2779134260 @default.
• W4285395144 hasConceptScore W4285395144C2779343474 @default.
• W4285395144 hasConceptScore W4285395144C2908647359 @default.
• W4285395144 hasConceptScore W4285395144C3008058167 @default.
• W4285395144 hasConceptScore W4285395144C44353895 @default.
• W4285395144 hasConceptScore W4285395144C511355011 @default.

• next